A wave of non-communicable diseases following the COVID-19 pandemic.
Reads0
Chats0
About:
This article is published in Diabetes and Metabolic Syndrome: Clinical Research and Reviews.The article was published on 2020-06-26 and is currently open access. It has received 49 citations till now. The article focuses on the topics: Pandemic.read more
Citations
More filters
Journal ArticleDOI
Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians.
TL;DR: Telemedicine is a useful tool for managing patients of diabetes during this lockdown period, however, there is limited data and further research is required.
Journal ArticleDOI
Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: A systematic review and meta-analysis.
RA Tuty Kuswardhani,Joshua Henrina,Raymond Pranata,Michael Anthonius Lim,Sherly Lawrensia,Ketut Suastika +5 more
TL;DR: CCI score should be utilized for risk stratifications of hospitalized COVID-19 patients and is prognostically associated with mortality and associated with a composite of poor outcomes.
Journal ArticleDOI
Body mass index and outcome in patients with COVID-19: A dose-response meta-analysis.
Raymond Pranata,Michael Anthonius Lim,Emir Yonas,Rachel Vania,Antonia Anna Lukito,Bambang Budi Siswanto,Markus Meyer +6 more
TL;DR: A meta-analysis of the dose-response relationship between body mass index (BMI) and poor outcome in patients with COVID-19 demonstrated that obesity was associated with composite poor outcome.
Journal ArticleDOI
Effect of heart failure on the outcome of COVID-19 - A meta analysis and systematic review.
Emir Yonas,Idrus Alwi,Raymond Pranata,Ian Huang,Michael Anthonius Lim,Eddy Jose Gutierrez,Muhammad Yamin,Bambang Budi Siswanto,Salim S. Virani +8 more
TL;DR: Patients with heart failure are at increased risk for hospitalization, poor outcome, and death from COVID-19, and the outcome of interest was mortality and poor prognosis in patients with preexisting heart failure with coronavirus disease.
Journal ArticleDOI
The Effect of Metformin Consumption on Mortality in Hospitalized COVID-19 patients: a systematic review and meta-analysis.
Antonia Anna Lukito,Raymond Pranata,Joshua Henrina,Michael Anthonius Lim,Sherly Lawrensia,Ketut Suastika +5 more
TL;DR: Preliminary findings showed that mortality was lowered in those who consume metformin vs who did not, and given its low cost and widespread availability, met formin is an attractive and potential regimen for mitigating excessive risk in diabetic populations.
References
More filters
Journal ArticleDOI
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era.
Salvatore De Rosa,Carmen Spaccarotella,Cristina Basso,Maria Pia Calabrò,Antonio Curcio,Pasquale Perrone Filardi,Massimo Mancone,Giuseppe Mercuro,Saverio Muscoli,Savina Nodari,Roberto Pedrinelli,Gianfranco Sinagra,Ciro Indolfi +12 more
TL;DR: Admissions for AMI were significantly reduced during the COVID-19 pandemic across Italy, with a parallel increase in fatality and complication rates.
Journal ArticleDOI
Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression.
TL;DR: DM was associated with mortality, severe COVID-19, ARDS, and disease progression in patients with CO VID-19 and the association was weaker in studies with median age ≥55 years-old compared to <55 years old, and in prevalence of hypertension ≥25% compared to<25%.
Journal ArticleDOI
Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations.
TL;DR: There is evidence of increased incidence and severity of CO VID-19 in patients with diabetes and COVID-19 could have effect on the pathophysiology of diabetes.
Journal ArticleDOI
Lymphopenia in severe coronavirus disease-2019 (COVID-19): Systematic review and meta-analysis
TL;DR: A systematic review and meta-analysis showed that lymphopenia on admission was associated with poor outcome in patients with COVID-19 and the association between lymphocyte count and composite poor outcome was affected by age.
Journal ArticleDOI
Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression.
Raymond Pranata,Michael Anthonius Lim,Ian Huang,Ian Huang,Sunu Budhi Raharjo,Antonia Anna Lukito +5 more
TL;DR: Hypertension was associated with increased composite poor outcome, including mortality, severe COVID-19, acute respiratory distress syndrome (ARDS), need for intensive care unit (ICU) care and disease progression in patients with CO VID-19.